Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Statistics

Total Valuation

STOK has a market cap or net worth of $652.83 million. The enterprise value is $376.68 million.

Market Cap	652.83M
Enterprise Value	376.68M

Important Dates

The next estimated earnings date is Tuesday, November 5, 2024, before market open.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	n/a

Share Statistics

STOK has 52.65 million shares outstanding. The number of shares has increased by 15.83% in one year.

Shares Outstanding	52.65M
Shares Change (YoY)	+15.83%
Shares Change (QoQ)	+20.58%
Owned by Insiders (%)	4.53%
Owned by Institutions (%)	78.18%
Float	31.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.23
Forward PS	50.85
PB Ratio	2.67
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	24.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.67, with a Debt / Equity ratio of 0.02.

Current Ratio	6.67
Quick Ratio	6.34
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -47.85% and return on invested capital (ROIC) is -32.34%.

Return on Equity (ROE)	-47.85%
Return on Assets (ROA)	-25.35%
Return on Capital (ROIC)	-32.34%
Revenue Per Employee	$137,791
Profits Per Employee	-$941,536
Employee Count	110
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +267.95% in the last 52 weeks. The beta is 0.96, so STOK's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+267.95%
50-Day Moving Average	13.39
200-Day Moving Average	11.68
Relative Strength Index (RSI)	46.99
Average Volume (20 Days)	445,277

Short Selling Information

The latest short interest is 6.79 million, so 12.89% of the outstanding shares have been sold short.

Short Interest	6.79M
Short Previous Month	6.98M
Short % of Shares Out	12.89%
Short % of Float	21.37%
Short Ratio (days to cover)	8.63

Income Statement

In the last 12 months, STOK had revenue of $15.16 million and -$103.57 million in losses. Loss per share was -$2.16.

Revenue	15.16M
Gross Profit	15.16M
Operating Income	-114.53M
Pretax Income	-103.57M
Net Income	-103.57M
EBITDA	-112.16M
EBIT	-114.53M
Loss Per Share	-$2.16

Balance Sheet

The company has $281.98 million in cash and $5.83 million in debt, giving a net cash position of $276.15 million or $5.25 per share.

Cash & Cash Equivalents	281.98M
Total Debt	5.83M
Net Cash	276.15M
Net Cash Per Share	$5.25
Equity (Book Value)	242.71M
Book Value Per Share	4.64
Working Capital	252.50M

Cash Flow

In the last 12 months, operating cash flow was -$79.95 million and capital expenditures -$670,000, giving a free cash flow of -$80.62 million.

Operating Cash Flow	-79.95M
Capital Expenditures	-670,000
Free Cash Flow	-80.62M
FCF Per Share	-$1.53

Margins

Gross Margin	100.00%
Operating Margin	-755.65%
Pretax Margin	-683.31%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-531.93%

Dividends & Yields

STOK does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.83%
Shareholder Yield	-15.83%
Earnings Yield	-15.86%
FCF Yield	-12.35%

Analyst Forecast

The average price target for STOK is $21.40, which is 72.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.40
Price Target Difference	72.58%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	79.37%
EPS Growth Forecast (5Y)	-19.19%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STOK has an Altman Z-Score of 1.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.06
Piotroski F-Score	2